Detalhe da pesquisa
1.
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer.
Oncologist
; 23(6): 654-e58, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438092
2.
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
N Engl J Med
; 370(11): 997-1007, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450857
3.
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
N Engl J Med
; 369(18): 1691-703, 2013 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24131140
4.
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
N Engl J Med
; 357(17): 1705-15, 2007 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-17960013
5.
Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia.
J Clin Oncol
; 37(16): 1391-1402, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995176
6.
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer.
Clin Colorectal Cancer
; 12(3): 218-22, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23810377
7.
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.
J Clin Oncol
; 31(32): 4105-14, 2013 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101053
8.
A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.
J Thorac Oncol
; 7(1): 196-202, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900836
9.
Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
Cancer
; 116(15): 3663-9, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20564147